PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.\', \'Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.\', \'Department of Surgery, Brigham and Women\'s Hospital, MA 02115, USA.\', \'Department of Cancer Cell Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.\', \'Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA.\', \'Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1139/cjpp-2020-0286
?:hasPublicationType
?:journal
  • Canadian journal of physiology and pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32640179
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.724
?:rankingScore_hIndex
  • 74
?:title
  • Current therapies under investigation for COVID-19: potential COVID-19 treatments.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32640179>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32640179>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all